3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
4
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
28
Prostatic Neoplasms
14
Neoplasm Metastasis
12
Osteoporosis
8
Multiple Myeloma
8
Pain
7
Lung Neoplasms
4
Fractures, Bone
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasms, Plasma Cell
3
Humoral Hypercalcemia Of Malignancy
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Paraproteinemias
1
Osteosarcoma
1
Neoplastic Processes
1
Lymphoma, Non-Hodgkin
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Diseases
1
Giant Cell Tumor of Bone
1
Disease Progression
1
Interventions
Methotrexate
4
Doxorubicin
3
Ifosfamide
2
Etoposide
2
Cisplatin
2
sodium thiosulfate
1
peginterferon alfa-2b
1
merphos
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Specimen Handling
1
Sodium Chloride
1
Restraint, Physical
1
Platinum
1
IMVP-16 protocol
1
Granulocyte Colony-Stimulating Factor
1
Fluoridation
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cyproheptadine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Osteosarcoma
×
Zoledronic Acid
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled